P. Lecoutre

Additive antisense effects of different PNAs on the in vitro translation of the PML/RARalpha gene.

P. Nielsen, C. Gambacorti-Passerini, L. Mologni, 1998, Nucleic acids research.

Decitabine: Where Is the Target?.

B. Dörken, M. Lübbert, I. Tamm, 2005 .

Nilotinib in chronic myeloid leukemia patients in chronic phase (CML-CP) with imatinib (IM) resistance or intolerance: Longer follow-up results of a phase II study.

R. Larson, M. Baccarani, K. Bhalla, 2016, Journal of Clinical Oncology.

Coincidence of Gaucher's disease due to a private mutation and Ph′ positive chronic myeloid leukemia

E. Beutler, P. Petrides, J. Müller‐Höcker, 1998, American journal of hematology.

Five new Gaucher disease mutations.

E. Beutler, A. Zimran, T. Gelbart, 1995, Blood cells, molecules & diseases.

Retrospective Cohort Analysis of Peripheral Arterial Occlusive Disease (PAOD) Events in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

F. Giles, G. Saglio, M. Mauro, 2011 .